Cellectar Biosciences, Inc. (CLRB)
NASDAQ·Healthcare·Biotechnology
$2.59
-0.77%
Mkt Cap $8.78M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 4, 2026 | $12.77M | — | — | -$1.19 | -$0.53 | +55.46% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$1.91 | -$1.41 | +26.18% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$3.60 | -$3.39 | +5.83% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$5.11 | -$3.90 | +23.68% | — | — |
| Q1 2025 Mar 13, 2025 | — | — | — | -$0.38 | -$0.01 | +97.37% | — | — |
| Q4 2024 Oct 29, 2024 | — | — | — | -$0.37 | -$0.51 | -37.84% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$0.23 | -$0.73 | -217.39% | — | — |
| Q2 2024 May 14, 2024 | — | — | — | -$0.50 | -$0.40 | +20.00% | — | — |
| Q1 2024 Mar 27, 2024 | — | $330.37K | — | -$0.59 | -$0.66 | -11.86% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$0.44 | -$0.82 | -86.36% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$0.69 | -$0.73 | -5.80% | — | — |
| Q2 2023 May 4, 2023 | — | — | — | -$0.75 | -$0.76 | -1.33% | — | — |
| Q1 2023 Mar 9, 2023 | — | — | — | -$0.83 | -$0.55 | +33.73% | — | — |
| Q4 2022 Nov 3, 2022 | — | — | — | -$1.21 | -$1.28 | -5.79% | — | — |
| Q3 2022 Aug 5, 2022 | — | — | — | -$1.08 | -$1.22 | -12.96% | — | — |
| Q2 2022 May 10, 2022 | — | — | — | -$1.10 | -$1.00 | +9.09% | — | — |
| Q1 2022 Mar 21, 2022 | — | — | — | -$1.00 | -$1.00 | +0.00% | — | — |
| Q4 2021 Nov 8, 2021 | — | — | — | -$1.10 | -$1.00 | +9.09% | — | — |
| Q3 2021 Aug 9, 2021 | — | — | — | -$1.10 | -$1.10 | +0.00% | — | — |
| Q2 2021 May 10, 2021 | — | — | — | -$0.90 | -$1.30 | -44.44% | — | — |